Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Free Cash Flow (2024 - 2025)

Profound Medical has reported Free Cash Flow over the past 2 years, most recently at -$6.6 million for Q4 2025.

  • Quarterly results put Free Cash Flow at -$6.6 million for Q4 2025, down 11.69% from a year ago — trailing twelve months through Dec 2025 was -$38.2 million (down 62.91% YoY), and the annual figure for FY2025 was -$38.4 million, down 63.66%.
  • Free Cash Flow for Q4 2025 was -$6.6 million at Profound Medical, up from -$9.6 million in the prior quarter.
  • Over the last five years, Free Cash Flow for PROF hit a ceiling of -$4.5 million in Q1 2024 and a floor of -$13.7 million in Q2 2025.